Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma

Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma

Bibliographic Details
Main Authors:	Dahlin, Amber, Litonjua, Augusto, Lima, John J., Tamari, Mayumi, Kubo, Michiaki, Irvin, Charles G., Peters, Stephen P., Tantisira, Kelan G.
Format:	Online
Language:	English
Published:	Public Library of Science 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470685/

Similar Items

Genome-wide association study of leukotriene modifier response in asthma
by: Dahlin, A, et al.
Published: (2016)

Genome Wide Association Study to predict severe asthma exacerbations in children using random forests classifiers
by: Xu, Mousheng, et al.
Published: (2011)

Childhood infections and asthma: at the crossroads of the hygiene and Barker hypotheses
by: Tantisira, Kelan G, et al.
Published: (2001)

Polymorphisms in signal transducer and activator of transcription 3 and lung function in asthma
by: Litonjua, Augusto A, et al.
Published: (2005)

Asthma phenotypes: the intriguing selective intervention with Montelukast
by: Marcello, Cottini, et al.
Published: (2016)

CMTR1 is associated with increased asthma exacerbations in patients taking inhaled corticosteroids
by: Dahlin, Amber, et al.
Published: (2015)

Predicting Inhaled Corticosteroid Response in Asthma with Two Associated SNPs
by: McGeachie, Michael J., et al.
Published: (2012)

Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene
by: Himes, Blanca E., et al.
Published: (2012)

Circulating microRNAs and prediction of asthma exacerbation in childhood asthma
by: Alvin T. Kho, et al.
Published: (2018-06-01)

Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
by: Scaparrotta, Alessandra, et al.
Published: (2012)

Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients
by: Scichilone, Nicola, et al.
Published: (2013)

Asthma in the elderly: a double-blind, placebo-controlled study of the effect of montelukast
by: Michele Columbo
Published: (2017-04-01)

Importin-13 genetic variation is associated with improved airway responsiveness in childhood asthma
by: Raby, Benjamin A, et al.
Published: (2009)

Vitamin D Modulates Expression of the Airway Smooth Muscle Transcriptome in Fatal Asthma
by: Himes, Blanca E., et al.
Published: (2015)

Montelukast in the management of allergic rhinitis
by: Lagos, Jaime A, et al.
Published: (2007)

Montelukast sodium-induced hypomania
by: Azhanie Sardangi
Published: (2015)

A polymorphism in the thyroid hormone receptor gene is associated with bronchodilator response in asthmatics
by: Duan, Qing Ling, et al.
Published: (2012)

Liver expression quantitative trait loci: a foundation for pharmacogenomic research
by: Glubb, Dylan M., et al.
Published: (2012)

Detecting Signals in Pharmacogenomic Genome-Wide Association Studies
by: Wakefield, Jon, et al.
Published: (2014)

A genome-wide association study of bronchodilator response in asthmatics
by: Duan, Qing Ling, et al.
Published: (2013)

Integration of Mouse and Human Genome-Wide Association Data Identifies KCNIP4 as an Asthma Gene
by: Himes, Blanca E., et al.
Published: (2013)

Pharmacogenomics
Published: (2008)

Pharmacogenomics
Published: (2008)

Sleeptalking! Sleepwalking! Side Effects of Montelukast
by: Alkhuja, Samer, et al.
Published: (2013)

Exercise-induced anaphylaxis and antileukotriene montelukast
by: Gajbhiye, Sapna, et al.
Published: (2015)

Is Montelukast Benefical in Children With Atopic Dermatitis?
by: Lee, Ai-Young
Published: (2016)

Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics
by: Ji, Yuan, et al.
Published: (2012)

Circulating MicroRNAs: Association with Lung Function in Asthma
by: Kho, Alvin T., et al.
Published: (2016)

Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D
by: Adkins, D E, et al.
Published: (2012)

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics
by: Beitelshees, Amber L, et al.
Published: (2015)

Human immunodeficiency virus therapeutics and pharmacogenomics
by: Shankarkumar, U., et al.
Published: (2011)

Clinical and Economic Outcomes Associated with Low-Dose Fluticasone Propionate Versus Montelukast in Children with Asthma Aged 4 to 11 Years
by: Stanford, Richard H, et al.
Published: (2012)

Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma
by: Stanford, Richard H, et al.
Published: (2012)

A randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation
by: Zubairi, Ali Bin Sarwar, et al.
Published: (2013)

Section 2. Exercise-Induced Bronchospasm: Albuterol versus Montelukast: Highlights of the Asthma Summit 2009: Beyond the Guidelines
by: Colice, Gene, et al.
Published: (2010)

Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses?
by: Hon, Kam Lun Ellis, et al.
Published: (2014)

Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort study
by: Bérubé, Denis, et al.
Published: (2014)

Prescription database analyses indicates that the asthma medicine montelukast might protect against dementia: a hypothesis to be verified
by: Bjørn Grinde, et al.
Published: (2017-08-01)

Comparison of oral montelukast with oral zileuton in acute asthma: A randomized, double-blind, placebo-controlled study
by: Magazine, Rahul, et al.
Published: (2016)

Comparison of Glucocorticoid (Budesonide) and Antileukotriene (Montelukast) Effect in Patients with Bronchial Asthma Determined with Body Plethysmography
by: Lajqi, Njomza, et al.
Published: (2015)